SUMMARY All patients under 60 years of age who were discharged from hospital after a first myocardial infarction between 1968 and 1977 in GCteborg were followed for a minimum of 24 months. The patients were unselected, and treatment was standardised. The patients were divided into five two yearly cohorts, and the prognostic comparability and mortality of these cohorts were assessed. There was a reduction in the two year mortality rate after discharge during the 10 year period. Small baseline differences between the cohorts were controlled by multivariate methods, and a subsequent analysis showed that there was a declining trend in mortality between 1968 and 1977. A higher tendency among smokers to give up smoking and a lower prevalence of angina pectoris could explain only part of the reduction in mortality. A small number of patients underwent a coronary bypass operation; the slight increase in the number of operations during the period cannot, however, account for the reduced mortality. Most of the patients in the later cohorts were treated with beta blockers, and this is the most likely explanation for the majority of the decline in mortality.
During the past decade the mortality due to coronary heart disease has declined in some Western countries.' -3 Changes in cardiovascular risk factors and improved medical care in the community have been proposed as explanations for this trend,<-3 as has improved care during admission to hospital. 4 The mortality after myocardial infarction accounts for about a third of the total coronary heart disease mortality. During the past decade there have been several studies of the effects of different secondary preventive measures such as cessation of smoking and long term beta blockade.5 6 Despite growing interest in secondary prevention it has been difficult to show any reduction in mortality after discharge from hospital among larger groups of patients.7-'0 In Goteborg, all patients in the middle-aged groups have been routinely followed up after myocardial infarction since 1968. We undertook this study, firstly, to investigate whether there was a change in mortality after myocardial infarction over the 10 year period and, secondly, to find explanations for any such change.
Since 1 January 1968 all cases of myocardial infarction occurring in Goteborg have been recorded by the Myocardial Infarction Register."I The present study comprised men and women who had had a first myocardial infarction and were selected as follows: for the two years 1968-69 all patients aged -55 years; for the two years 1970-71 all patients aged si59 years (except a random 300/o sample of those aged 57-59 years who formed a reference group); for 1972 every other patient <60 years; and for 1973 up to 31 December 1977 all patients <60 years. Thus a total of 1322 patients who survived until discharge from hospital were studied (Table 1 ).
QUESTIONNAIRES
After discharge the patients were treated according to a uniform regimen agreed at regular staff meetings. Physical examinations were undertaken at intervals dictated by the patients' clinical condition and always at one, three, 12, and 24 months after infarction.'2 Patients who were not able to visit the clinic were offered new appointments, and patients who had moved to other areas were encouraged to fill in questionnaires sent to them. For all interviews and physical examinations identical questionnaires were completed by the same investigators. The form for the period of hospital stay contained questions about Declining trend in mortality after myocardial infarction Total   <34  14  2  16  35-39  25  5  30  40-44  83  13  96  45-49  196  28  224  50-54  374  70  444  55-59  421  91  512  Total  1113  209  1322 demographic details and previous diseases, cardiovascular and respiratory symptoms, smoking habits, amount of physical activity undertaken at work and during leisure, and clinical condition at the onset of the disease, during hospital admission, and at discharge. The 
MANAGEMENT
All patients were informed about the association bet-347 ween smoking and ischaemic heart disease. The smokers were advised to stop smoking. Persisting hypertension during the follow up period was treated with a beta blocker or a diuretic or a combination of both. General dietary information was given to the patients during admission for myocardial infarction and also at the postmyocardial infarction clinic. When the serum cholesterol concentration was 7-8 mmolI (300 mg/dl) or higher specific dietary advice was given, sometimes by a dietitian, and a lipid reducing agent prescribed, both at the discretion of the physician. Treatment with lipid reducing agents never exceeded 8% in the highest cholesterol quintile among the patients in the study.
Treatment during follow up was otherwise based on formalised criteria. In 1975 the findings of several trials of beta blockade were adopted, and alprenolol was given routinely to all patients in whom beta blockade was not contraindicated.
MORTALITY DATA
Mortality was established by the Myocardial Infarction Register by continuous checking of all national death certificates." I Death certificates for all inhabitants of Goteborg were sent to the Myocardial Infarction Register, even if the death occurred outside the city or abroad. In a small number of patients who moved from Goteborg during the follow up period the death certificates issued in the new city or county were routinely checked at the three month, 12 month, and 24 month examinations. In this study all causes of mortality were analysed. As a further check on survival, patients who failed to keep their appointment at the postmyocardial infarction clinic were followed up.
All the patients in this study were followed for 24 months. In this study they were divided into five two yearly cohorts from 1968 to 1977. The total mortality and the levels of primary and secondary risk factors were analysed for these five cohorts.
STATISTICAL METHODS
The extensions of Mantel-Haenszel's procedure were used to test the linear trend of survival curves through the years 1968 to 1977. 14 Table 1 shows the age distribution of the 1113 men and 209 women included in the study.
The prognostic comparability of the different two yearly cohorts was assessed. Table 2 shows the patients' characteristics before infarction. The prevalence of angina pectoris before infarction decreased from nearly 500/o in the first cohort to just over 300% in the last cohort (p=0.0006). The percentage of smokers at the time of infarction decreased from 92% in the first cohort to 72% in the last (p=0*018). No such trend was found for the other variables. Table 3 shows the variables recorded during hospital admission. For methodological reasons the patients in the first cohort were younger. The mean peak serum aspartate transaminase activity and the frequency of atrial arrhythmias decreased during the 10 year period (p=0*0005 and p=0*035), but the other variables remained stable. During admission digitalis was given less frequently (p=0-12) and diuretics more frequently (p<0C0001). Table 4 shows the percentage of smokers who stopped smoking and that of patients who were treated with beta blockers in the different cohorts. More smokers stopped smoking (p=0-025), and more patients were treated with beta blockers (p<0-0001) in the later cohorts.
Among all patients there was a total of 117 deaths after discharge from hospital during the first 24 months of follow up. Table 5 shows the crude mortal- ity rate after 24 months for the five cohorts. Despite large variations between the cohorts there was a general decline in mortality rate (p=0-029). Fig. 1 shows the cumulative mortality curves. The difference in mortality between the early and late cohorts was mainly due to a low mortality during the first three months in the later cohorts (p= 0 018). Fig. 2 shows the different two year mortality rates for the five cohorts: the crude mortality rates as above, the mortality rates standardised to the mean age and prognosis of all patients, and the mortality estimated by the Cox model. The Cox analysis showed that mortality after discharge from hospital was still declining (p<O004) when adjusted for the expected prognosis and age.
Discussion
The patients in this study were unselected, and the methods used were standardised and unchanged throughout the follow up.'2 18 The number of patients who could not be followed up was negligible.'2 The reliability of end points (in this case deaths from various causes) had been assessed. 18 The different cohorts studied were comparable with regard to many of the characteristics before infarction, but there were some differences in the prevalence of angina pectoris and smoking habits. Perhaps the widespread use of beta blockers in the late 1970s was the reason for the decreasing percentage of patients with angina pectoris before myocardial infarction. During the 10 year period the number of coronary bypass operations was less than 3% in any of the cohorts.
To compare the two year mortality rates after discharge from hospital for the different cohorts we standardised for factors of prognostic importance after myocardial infarction.16 In this study the declining mortality after infarction was independent of age and estimated probability of death within two years. It was also independent of the lower frequency of atrial arrhythmias. During the study less digitalis and more diuretics were used in the treatment of left ven-tricular failure, but this variable did not change during the study.
There may be several explanations for the decline in mortality. The total cardiovascular mortality in the Goteborg area was stable during the study period. 19 This does not contradict the results in our study since the mortality after myocardial infarction is only a part of the cardiovascular mortality. Mortality before admission to hospital might have been increasing so that more patients died before admission and, therefore, did not influence the follow up mortality.
Hospital mortality probably decreased during the 1960s and 1970s because of the improved care offered by more coronary care units and the improved diagnosis and treatment of life threatening arrhythmias. 20 The hospital mortality may also have decreased during the study period because the length of admission fell from about 19 days to about 11 days. The lower mortality in hospital due to the shorter stay would, however, tend to increase mortality later during the follow up period. The mortality trends after myocardial infarction have been standardised for factors reflecting the severity of infarction that predict mortality during this period. '6 The primary cardiovascular risk factors might have been influenced by changes in life style, dietary habits, physical fitness, and perhaps a more aggressive approach to the detection and control of hypertension. This influence has been claimed to be the most important explanation for the decline in cardiovascular mortality in some Western countries. 22 A change in the selection of patients for admission to hospital could influence the mortality rate after myocardial infarction. The increase in the general awareness of symptoms of myocardial infarction may have resulted in patients with milder symptoms being admitted to hospital. This was not true, however, in this series, since there was no consistent increase in the number of patients admitted (Table 2) . Furthermore, the Cox analysis would prevent such differences between cohorts influencing the results.
Smoking after myocardial infarction is well established as a powerful secondary risk factor.5 In this study there was an increase in the percentage of patients who stopped smoking. In previous studies of the effects of stopping smoking, this had only very limited effects on mortality during early follow up. 23 There are now several studies of the relation between treatment with beta blockers after myocardial infarction and the reduction of deaths and non-fatal reinfarctions.624 The first of these studies,24 our own, was published in 1974 and led to a massive increase in the percentage of patients treated with beta blockers in the middle of the 1970s; in the last three cohorts up to nearly 700/o of patients were treated. This could be a major contributory factor explaining the result. The effect of beta blockade could not be analysed more closely for several reasons. Firstly, because treatment with beta blockers in the early cohorts was restricted to patients with hypertension and angina pectoris and was rare-the numbers of patients and possible end points were too few. Secondly, in the last two cohorts most patients were treated with beta blockers. Those not treated cannot, however, be easily compared with those who were because they had contraindications for beta blockade-for example, severe cardiac failure, chronic bronchitis or asthma, or diabetes mellitus. Thus these patients would be heavily biased towards a bad prognosis even after adjustment with the prognostic model used.
Since the secular declining trend in mortality was particularly pronounced during the first three months these findings indicate an early effect of beta blockade. 6 A few studies suggest the possibility of a declining mortality after discharge from hospital.8- 10 20 Hunt et al found a lower one year mortality rate after acute myocardial infarction later in the observation period.20 These workers also proposed beta blockade as an explanation. The findings of the other studies were, however, not conclusive. The latest study used a technique similar to the one in this study. IO In that study, however, the patients were included up to 12 months after myocardial infarction,'0 and any differences in early mortality might easily have been missed. Furthermore, as judged from the report, treatment with beta blockers was not common in those patients.
The present study showed an encouraging decrease in mortality after myocardial infarction after discharge from hospital between 1%8 and 1977. The reduction, which was independent of age and estimated risk, could not have been due solely to a change in smoking habits or to the prevalence of angina before infarction. The mortality in the later years was 280/o lower than that in earlier years. The size of this reduction is comparable with that found in the major trials of beta blockers.6 As most patients were treated with beta blockers during these years a decline in mortality of this order would be predicted, and treatment with beta blockers is most likely to be the chief explanation. myocardial infarction. 
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